RT @DrLahariya: .@ICMRDELHI , #India’s first official #HTA study, cost effectiveness of Safety Engineered Syringes #RUP #SIP published. Op…
RT @DrLahariya: .@ICMRDELHI , #India’s first official #HTA study, cost effectiveness of Safety Engineered Syringes #RUP #SIP published. Op…
RT @DrLahariya: .@ICMRDELHI , #India’s first official #HTA study, cost effectiveness of Safety Engineered Syringes #RUP #SIP published. Op…
RT @DrLahariya: .@ICMRDELHI , #India’s first official #HTA study, cost effectiveness of Safety Engineered Syringes #RUP #SIP published. Op…
.@ICMRDELHI , #India’s first official #HTA study, cost effectiveness of Safety Engineered Syringes #RUP #SIP published. Open access. @ProfBhargava @MoHFW_INDIA @WHO @doctorsoumya @asoucat @NeelamDhingra1 @etkelley419 @Mundra08 #UHC @drharshvardhan h
#HealthEconJA Cost-Effectiveness of Therapeutic Use of Safety-Engineered Syringes in Healthcare Facilities in India https://t.co/nCPbIsfdIc